In a clinical trial that could lead to treatments that prevent Alzheimer’s disease, people who are genetically guaranteed to suffer from the disease years from now — but who do not yet have any symptoms — will for the first time be given a drug intended to stop them from developing it, federal officials announced Tuesday. NYT